Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of -103.00% is 712% below its 5-year average of -12.69%, near the low end of its 5-year range (-103.00%–8.79%).
158.70% below its 12-month average of -39.81%.
Reported quarterly return on assets; no daily interpolation. Q2 FY2026 (2026-06-30): -8.47%.
RETURN ON ASSETS (ROA)
-103.00%
RETURN ON ASSETS (ROA) AVG TTM
-39.81%
RETURN ON ASSETS (ROA) AVG 3Y
-17.36%
RETURN ON ASSETS (ROA) AVG 5Y
-12.69%
RETURN ON ASSETS (ROA) AVG 10Y
N/A
RETURN ON ASSETS (ROA) AVG 15Y
N/A
RETURN ON ASSETS (ROA) AVG 20Y
N/A
CURRENT VS TTM AVG
-158.70%
CURRENT VS 3Y AVG
-493.32%
CURRENT VS 5Y AVG
-711.98%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-28.05%
median of 560 covered companies
CURRENT VS SECTOR MEDIAN
-267.27%
vs the sector median at left
DocGo Inc.
Market Cap
$36.70M
Return on Assets (ROA)
-103.00%
TTM Avg
-39.81%
3Y Avg
-17.36%
5Y Avg
-12.69%
Market Cap
$37.14M
Return on Assets (ROA)
-11.09%
TTM Avg
-5.71%
3Y Avg
-4.17%
5Y Avg
-3.19%
Market Cap
$35.58M
Return on Assets (ROA)
-136.91%
TTM Avg
-90.70%
3Y Avg
-79.79%
5Y Avg
-214.88%
Market Cap
$36.32M
Return on Assets (ROA)
-120.78%
TTM Avg
-168.59%
3Y Avg
-147.82%
5Y Avg
-131.31%
Market Cap
$35.82M
Return on Assets (ROA)
118.69%
TTM Avg
-31.86%
3Y Avg
-49.56%
5Y Avg
-43.59%
Market Cap
$37.81M
Return on Assets (ROA)
-110.85%
TTM Avg
-107.44%
3Y Avg
-115.17%
5Y Avg
-101.88%
Market Cap
$38.60M
Return on Assets (ROA)
-13.65%
TTM Avg
-40.30%
3Y Avg
-22.41%
5Y Avg
-15.81%
Market Cap
$38.82M
Return on Assets (ROA)
-26.45%
TTM Avg
-127.88%
3Y Avg
-142.31%
5Y Avg
-121.77%
Market Cap
$34.44M
Return on Assets (ROA)
-42.84%
TTM Avg
-15.31%
3Y Avg
-31.73%
5Y Avg
-29.34%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| DocGo Inc. (DCGO) | $36.70M | -103.00% | -39.81% | -17.36% | -12.69% |
| Accuray Incorporated (ARAY)vs › | $37.14M | -11.09% | -5.71% | -4.17% | -3.19% |
| BriaCell Therapeutics Corp. (BCTX)vs › | $35.58M | -136.91% | -90.70% | -79.79% | -214.88% |
| Elicio Therapeutics, Inc. (ELTX)vs › | $36.32M | -120.78% | -168.59% | -147.82% | -131.31% |
| Elutia Inc (ELUT)vs › | $35.82M | 118.69% | -31.86% | -49.56% | -43.59% |
| Edesa Biotech, Inc. (EDSA)vs › | $37.81M | -110.85% | -107.44% | -115.17% | -101.88% |
| Harvard Bioscience, Inc. (HBIO)vs › | $38.60M | -13.65% | -40.30% | -22.41% | -15.81% |
| Incannex Healthcare Limited (IXHL)vs › | $38.82M | -26.45% | -127.88% | -142.31% | -121.77% |
| Grace Therapeutics, Inc. (GRCE)vs › | $34.44M | -42.84% | -15.31% | -31.73% | -29.34% |
| HeartBeam, Inc. (BEAT)vs › | $33.31M | -190.81% | -476.65% | -339.92% | -580.90% |
ROA
-103.0%
ROE
-161.6%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | -84.02% |
| 2024-12-31 | 4.39% |
| 2023-12-31 | 1.40% |
| 2022-12-31 | 8.79% |
| 2021-12-31 | 7.67% |
| 2020-12-31 | -14.34% |
| 2019-12-31 | -20.02% |
